This thus applies to measures that, on the one hand, meet the objective of guaranteeing in the territory of the Member State concerned sufficient and permanent access to a balanced range of high-quality medical treatment and, on the other, are intended to ensure cost efficiency and prevention, as far as possible, of any wastage of financial, technical and human resources (see, to that effect, judgment of 28 January 2016, CASTA and Others, C‐50/14, EU:C:2016:56, paragraph 60 and paragraph 61).
Kérj bátran, ember!eurlex-diff-2018-06-20 eurlex-diff-2018-06-20